Structured evidence table for Lactoferrin Supplementation Acne Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lactoferrin Supplementation Acne Randomized Trial | Cutibacterium acnes Propionibacterium acnes 6 7 The pathogenesis of acne is multifactorial, arising from the interplay of increased sebum production, abnormal follicular keratinization, colonization with(formerly), and inflammation with contributions from genetic, hormonal, and environmental factors []. | 1 | Warp Peyton V. (2026) | Prebiotics, Probiotics, and Postbiotics for Acne Vulgaris: A Systematic Review |
| Lactoferrin Supplementation Acne Randomized Trial | Limited studies of gut microbiota in patients with acne have identified overall reduced diversity, a higher Bacteroidetes:Firmicutes ratio, enrichment of Proteobacteria, depletion of Actinobacteria, and loss of beneficial genera, includingand[–]. | 1 | Warp Peyton V. (2026) | Prebiotics, Probiotics, and Postbiotics for Acne Vulgaris: A Systematic Review |
| Lactoferrin Supplementation Acne Randomized Trial | Several studies had unclear risk in selective reporting and performance bias, though outcome data were typically transparent and comprehensive. | 1 | Warp Peyton V. (2026) | Prebiotics, Probiotics, and Postbiotics for Acne Vulgaris: A Systematic Review |
| Lactoferrin Supplementation Acne Randomized Trial | The gut–skin axis and human microbiome likely play a role in the pathogenesis of acne vulgaris. | 1 | Warp Peyton V. (2026) | Prebiotics, Probiotics, and Postbiotics for Acne Vulgaris: A Systematic Review |
Source documents